Innovación, terapia y desarrollo farmacéutico en oftalmología
INNOFTAL
![Foto de Innovación, terapia y desarrollo farmacéutico en oftalmología](/img/grupo.png)
![Foto de Universitat de València](/img/noimage_org.png)
Universitat de València
Valencia, EspañaUniversitat de València-ko ikertzaileekin lankidetzan egindako argitalpenak (7)
2024
-
Efficacy and safety of intense pulsed light of upper and lower eyelids in Meibomian gland dysfunction: A prospective multicentric study
European Journal of Ophthalmology, Vol. 34, Núm. 3, pp. 700-707
2021
-
Tear 1H Nuclear Magnetic Resonance-Based Metabolomics Application to the Molecular Diagnosis of Aqueous Tear Deficiency and Meibomian Gland Dysfunction
Ophthalmic Research, Vol. 64, Núm. 2, pp. 297-309
2019
-
Cytokine expression in tears of patients with glaucoma or dry eye disease: A prospective, observational cohort study
European Journal of Ophthalmology, Vol. 29, Núm. 4, pp. 437-443
2015
-
Specific association of IL17A genetic variants with panuveitis
British Journal of Ophthalmology, Vol. 99, Núm. 4, pp. 566-570
2013
-
Effects of a nutraceutical formulation based on the combination of antioxidants and ω-3 essential fatty acids in the expression of inflammation and immune response mediators in tears from patients with dry eye disorders
Clinical Interventions in Aging, Vol. 8, pp. 139-148
-
Patients undergoing long-term treatment with antihypertensive eye drops responded positively with respect to their ocular surface disorder to oral supplementation with antioxidants and essential fatty acids
Clinical Interventions in Aging, Vol. 8, pp. 711-719
1990
-
A study of the adrenergic activity of the alkaloids boldine and glaucine
Pharmazie, Vol. 45, Núm. 6, pp. 443-444